Figure 6.

Distant relapse‐free survival of breast cancer patients according to p‐Akt and/or Vav1 status of their primary tumors. (A) Kaplan–Meier estimates of distant relapse‐free survival (DRFS) in patients (n = 126) according to p‐Akt status. (B) Kaplan–Meier estimates of DRFS in patients with p‐Akt^high tumors (n = 38) (left panel), and in patients with p‐Akt^low tumors (n = 88) (right panel), according to high (green solid line) and low (blue dashed line) expression of Vav1. In these cohort of patients, a distant relapse occurred in the 11% (10/88) p‐Akt^low and 13% (5/38) p‐Akt^high tumors, in the 16% (4/25) Vav1^low and 8% (1/13) Vav1^high of patients with p‐Akt^high tumors, and in the 23% (8/35) Vav1^low and 4% (2/53) Vav1^high of patients with p‐Akt^low tumors.